RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2019; 30(07): 857-859
DOI: 10.1055/s-0037-1611760
DOI: 10.1055/s-0037-1611760
letter
One-Pot Regioselective Synthesis of 2,5,6,7-Tetrahydroimidazo [1,2-a]imidazol-3-ones Starting from (Vinylimino)phosphoranes
We gratefully acknowledge financial support of this work by the National Natural Science Foundation of China (Nos. 21572075 and 21602052), the 111 Project B17019, the Natural Science Foundation of Hubei province (No. 2014CFB567), and Research Startup Funding of Hubei University of Education Grant.Weitere Informationen
Publikationsverlauf
Received: 27. Januar 2019
Accepted after revision: 20. Februar 2019
Publikationsdatum:
26. März 2019 (online)
![](https://www.thieme-connect.de/media/synlett/201907/lookinside/thumbnails/st-2019-l0044-l_10-1055_s-0037-1611760-1.jpg)
Abstract
A new, one-pot, regioselective preparation of 2,5,6,7-tetrahydroimidazo[1,2-a]imidazol-3-ones by a sequential aza-Wittig/nucleophilic addition/cyclization reaction was developed. The aza-Wittig reactions of ethyl (2Z)-3-aryl-2-[(triphenylphosphoranylidene)amino] acrylates with aryl isocyanates produced carbodiimide intermediates that were then treated sequentially with 2-aminoethanol and tosyl chloride/triethylamine to give the corresponding (2Z)-2-[(substituted)benzylidene]-2,5,6,7-tetrahydro-3H-imidazo[1,2-a]imidazol-3-ones in good overall yields and with high regioselectivity.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1611760.
- Supporting Information
-
References and Notes
- 1a Liao W, Hu G, Guo Z, Sun D, Zhang L, Bu Y, Li Y, Liu Y, Gong P. Bioorg. Med. Chem. 2015; 23: 4410
- 1b Kamal A, Ramakrishna G, Raju P, Viswanath A, Ramaiah MJ, Balakishan G, Pal-Bhadra M. Bioorg. Med. Chem. Lett. 2010; 20: 4865
- 1c Sheppeck JE. II, Gilmore JL, Tebben A, Xue C.-B, Liu R.-Q, Decicco CP, Duan JJ.-W. Bioorg. Med. Chem. Lett. 2007; 17: 2769
- 2 Durdagi S, Aksoydan B, Erol I, Kantarcioglu I, Ergun Y, Bulut G, Acar M, Avsar T, Liapakis G, Karageorgos V, Salmas RE, Sergi B, Alkhatib S, Turan G, Nur Yigit B, Cantasir K, Kurt B, Kilic T. Eur. J. Med. Chem. 2018; 145: 273
- 3 Li Y.-W, Liu J, Liu N, Shi D, Zhou X.-T, Lv J.-G, Zhu J, Zheng C.-H, Zhou Y.-J. Bioorg. Med. Chem. 2011; 19: 3579
- 4a Meurer LC, Finke PE, Owens KA, Tsou NN, Ball RG, Mills SG, MacCoss M, Sadowski S, Cascieri MA, Tsao K.-L, Chicchi GG, Egger LA, Luell S, Metzger JM, MacIntyre DE, Rupniak NM. J, Williams AR, Hargreaves RJ. Bioorg. Med. Chem. Lett. 2006; 16: 4504
- 4b Finke PE, Meurer LC, Levorse DL, MacCoss M, Sadowski S, Cascieri MA, Tsao K.-L, Chicchi GG, Metzger JM, MacIntyre DE. Bioorg. Med. Chem. Lett. 2006; 16: 4497
- 5 Sato H, Tsuda M, Watanabe K, Kobayashi J. Tetrahedron 1998; 54: 8687
- 6 Chan GW, Mong S, Hemling ME, Freyer AJ, Offen PH, DeBrosse CW, Sarau HM, Westley JW. J. Nat. Prod. 1993; 56: 116
- 7 Gutiérrez S, Martínez-Lóez D, Morón M, Sucunza D, Sampedro D, Domingo A, Salgado A, Vaquero JJ. Chem. Eur. J. 2015; 21: 18758
- 8 Chuang W.-T, Chen B.-S, Chen K.-Y, Hsieh C.-C, Chou P.-T. Chem. Commun. 2009; 6982
- 9 You Y, He Y, Burrows PE, Forrest SR, Petasis NA, Thompson ME. Adv. Mater. (Weinheim, Ger.) 2000; 12: 1678
- 10 Djukanovic D, Petkovic M, Simic M, Jovanovic P, Tasic G, Savic V. Tetrahedron Lett. 2018; 59: 914
- 11 Dražić T, Vazdar K, Vazdar M, Ðaković M, Mikecin A.-M, Kralj M, Malnar M, Hećimović S, Habuš I. Tetrahedron 2015; 71: 9202
- 12 Zhao H, Wang R, Chen P, Gregg BT, Hsia MM, Zhang W. Org. Lett. 2012; 14: 1872
- 13 Bezenšek J, Grošelj U, Stare K, Svete J, Stanovnik B. Tetrahedron 2012; 68: 516
- 14 He X, Bell AF, Tonge PJ. Org. Lett. 2002; 4: 1523
- 15 Janongsik T, Johnson A.-L, Bergman J. Tetrahedron 2002; 58: 2813
- 16 Gong X, Yang H, Liu H, Jiang Y, Zhao Y, Fu H. Org. Lett. 2010; 12: 3128
- 17a Liu Y, He P, Zhang Y, Zhang X, Liu J, Du Y. J. Org. Chem. 2018; 83: 3897
- 17b Jayaram V, Sridhar T, Sharma GV. M, Berrée F, Carboni B. J. Org. Chem. 2018; 83: 843
- 17c Wei J, Nie BJ, Peng R, Cheng XH, Wang S, He P. Synlett 2016; 27: 626
- 17d Qiao J, Liu Y, Du Y. Tetrahedron 2018; 74: 3061
- 17e Subota AI, Artamonov OS, Gorlova A, Volochnyuk DM, Grygorenko OO. Tetrahedron Lett. 2017; 58: 1989
- 17f Nishimura Y, Kubo T, Okamoto Y, Cho H. Tetrahedron Lett. 2017; 58: 4236
- 17g Arques A, Molina P. Curr. Org. Chem. 2004; 8: 827
- 17h Palacios F, Alonso C, Aparicio D, Gloria Rubiales G, de los Santos JM. Tetrahedron 2007; 63: 523
- 17i Palacios F, Aparicio D, Rubiales G, Alonso C, de los Santos JM. Curr. Org. Chem. 2006; 10: 2371
- 18a Bleda JA, Fresneda PM, Orenes R, Molina P. Eur. J. Org. Chem. 2009; 2490
- 18b Naganaboina VK, Chandra KL, Desper J, Rayat S. Org. Lett. 2011; 13: 3718
- 18c Bellucci MC, Frigerio M, Castellano C, Meneghetti F, Sacchetti A, Volonterio A. Org. Biomol. Chem. 2018; 16: 521
- 18d Walker JD, Madalengoitia JS. Tetrahedron Lett. 2015; 56: 3786
- 18e Bellucci MC, Sani M, Sganappa A, Volonterio A. ACS Comb. Sci. 2014; 16: 711
- 19 Ruijter E, Scheffelaar R, Orru RV. A. Angew. Chem. Int. Ed. 2011; 50: 6234
- 20a Xiong J, Wei X, Ding M.-W. Synlett 2017; 28: 1075
- 20b Zeng G.-P, Cai C.-Q, Tan F, Ding M.-W. Chin. Chem. Lett. 2015; 26: 1158
- 20c Xie H, Liu J.-C, Wu L, Ding M.-W. Tetrahedron 2012; 68: 7984
- 20d Zhong Y, Wu L, Ding M.-W. Synthesis 2012; 44: 3085
- 20e Li H.-X, Xie C, Ding M.-W, Liu Z.-M, Yang G.-F. Synlett 2007; 2280
- 21 CCDC 1862199 contains the supplementary crystallographic data for compound 6ab. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
- 22 (2Z)-2-Benzylidene-7-(4-tolyl)-2,5,6,7-tetrahydro-3H-imidazo[1,2-a]imidazol-3-one (6ab); Typical Procedure (Vinylimino)phosphorane 1a (2.26 g, 5 mmol) was treated with 4-tolyl isocyanate (2b; 0.67 g, 5 mmol) in CH2Cl2 (15 mL) at r.t. for 4 h to give carbodiimide 3ab (monitored by TLC), which was used directly in the next step. Ph3P=O was extracted from the mixture with 1:2 Et2O–PE (20 mL), and carbodiimide 3ab was treated with 2-aminoethanol (4; 0.60 mL, 5 mmol) in CH2Cl2 (15 mL) with stirring for 4 h. The mixture was then concentrated and the residue was dissolved in MeCN (25 mL). Et3N (2.8 mL, 20 mmol) was added, followed after 30 min by TosCl (1.05 g, 5.5 mmol). The mixture was then stirred at r.t. for about 6 h until 5ab was completely consumed (TLC). The reaction was quenched with sat. aq NH4Cl, and the mixture was extracted with CH2Cl2. The extracts were dried (Na2SO4) and the crude mixture was purified directly by flash column chromatography [silica gel PE–CH2Cl2 (4:1 to 2:1)] to give a light-yellow solid; yield: 1.24 g (82%); mp 196–198 °C.IR: 2954, 2924, 2854, 1730, 1659, 1603, 1591, 1565, 1519, 1492, 1459, 1376, 1305 cm–1. 1H NMR (600 MHz, CDCl3): δ = 8.09 (d, J = 7.6 Hz, 2 H), 7.64 (d, J = 8.4 Hz, 2 H), 7.41 (t, J = 7.6 Hz, 2 H), 7.31 (t, J = 7.3 Hz, 1 H), 7.27–7.23 (m, 2 H), 6.76 (s, 1 H), 4.40–4.31 (m, 2 H), 4.00–3.90 (m, 2 H), 2.36 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 166.3, 158.7, 145.2, 135.9, 135.0, 133.2, 130.9, 129.8, 128.5, 128.4, 119.0, 117.1, 50.7, 36.7, 20.8. HRMS (ESI): m/z [M + H]+ calcd for C19H18N3O: 304.1450; found: 304.1444.